Skip to main content
Goetz Kloecker, MD, Oncology, Louisville, KY

Goetz Kloecker MD

Hematologic Oncology, Thoracic Cancer


Professor, Medicine, University of Louisville School of Medicine

Join to view full profile
  • 529 S Jackson StLouisville, KY 40202

  • Phone+1 502-562-4370

  • Fax+1 502-562-4373

Dr. Kloecker is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Louisville School of Medicine
    University of Louisville School of MedicineFellowship, Hematology and Medical Oncology, 2001 - 2003
  • University of Louisville School of Medicine
    University of Louisville School of MedicineResidency, Internal Medicine, 1994 - 1997
  • Technical University Munich Faculty of Medicine
    Technical University Munich Faculty of MedicineClass of 1990

Certifications & Licensure

  • KY State Medical License
    KY State Medical License 1997 - 2027
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Hematology
    American Board of Internal Medicine Hematology
  • Hospice and Palliative Medicine
    American Board of Internal Medicine Hospice and Palliative Medicine
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Experts Stress Lung Cancer Screenings as Kentucky Ranks Worst in US for New Cases
    Experts Stress Lung Cancer Screenings as Kentucky Ranks Worst in US for New CasesNovember 19th, 2025
  • This Week’s Books in Medicine
    This Week’s Books in MedicineDecember 4th, 2020
  • Plinabulin Combo with Docetaxel Aimed at Delivering a "Double Hit" in NSCLC Trial
    Plinabulin Combo with Docetaxel Aimed at Delivering a "Double Hit" in NSCLC TrialJanuary 3rd, 2018

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: